Budesonideformoterol vs. salmeterolfluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials
International Journal of Clinical Practice,  Clinical Article

Halpin DMG et al. – The results of the indirect comparison support the hypothesis that budesonide/formoterol is associated with fewer pneumonia events than salmeterol/fluticasone in chronic obstructive pulmonary disease. The limitations of the analysis are that the results from a single study, TORCH, have a large bearing on the overall findings of the analysis, and that there is heterogeneity in the length and the dosing of the included studies, although it does not appear that heterogeneity affected the reported results. Another important limitation is the lack of predefined diagnostic standards for pneumonia in these studies.

Methods
  • An initial literature search revealed no suitable head-to-head trials between budesonide/formoterol and salmeterol/fluticasone and therefore a systematic review was conducted to find randomised controlled trials providing data for input into an adjusted indirect comparison of the two combination treatments using placebo as a common comparator.
  • The Bucher adjusted indirect comparison method was used to calculate odds ratios and 95% confidence intervals.

Results
  • Eight salmeterol/fluticasone trials and four budesonide/formoterol trials were identified as being relevant for the analyses.
  • The proportion of patients experiencing a pneumonia adverse event was significantly lower with budesonide/formoterol than salmeterol/fluticasone (odds ratio, 0.47; 95% confidence interval, 0.28-0.80).
  • The proportion of patients experiencing a pneumonia serious adverse event was also significantly lower with budesonide/formoterol than salmeterol/fluticasone (odds ratio, 0.41; 95% confidence interval, 0.19-0.86).
  • However, there were too few events to draw any firm conclusions on pneumonia-related mortality.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

2 Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease Respiratory Medicine, September 19, 2014    Clinical Article

3 Efficacy of azithromycin in the treatment of bronchiectasis Respirology, September 9, 2014    Clinical Article

4 Prevalence of chronic obstructive pulmonary disease among US working adults aged 40 to 70 years: National Health Interview Survey data 2004 to 2011 Journal of Occupational and Environmental Medicine, October 17, 2014    Clinical Article

5 Efficacy of mycophenolate mofetil in sarcoidosis Respiratory Medicine, October 29, 2014    Review Article

6 The effects of high intensity exercise during pulmonary rehabilitation on ventilatory parameters in people with moderate to severe stable COPD: A systematic review Full Text International Journal of COPD, October 14, 2014    Free full text    Evidence Based Medicine    Clinical Article

7 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

8 Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD Full Text International Journal of COPD, October 24, 2014    Free full text    Clinical Article

9 Predictors of physical inactivity in elderly patients with chronic obstructive pulmonary disease Full Text International Journal of Gerontology, September 25, 2014    Free full text    Clinical Article

10 Prophylactic antibiotic therapy after inhalation injury Burns, October 10, 2014    Clinical Article

11 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

12 Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis Chest, September 9, 2014    Clinical Article

13 The clinical features of sarcoidosis: a comprehensive review Clinical Reviews in Allergy and Immunology, October 10, 2014    Clinical Article

14 Comparison of US emergency department acute asthma care quality: 1997-2001 and 2001-2012 The Journal of Allergy and Clinical Immunology, October 7, 2014    Clinical Article

15 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

16 Benefits of an oxygen reservoir cannula versus a conventional nasal cannula during exercise in hypoxemic COPD patients: A crossover trial Respiration, October 21, 2014    Clinical Article

17 Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: A post-hoc analysis of the 4-year UPLIFT trial Full Text BMC Pulmonary Medicine, October 22, 2014    Free full text    Clinical Article

18 Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease Respiratory Medicine, October 3, 2014    Clinical Article

19 The use of N-acetylcysteine in respiratory diseases Current Respiratory Medicine Reviews, July 17, 2014    Review Article

20 Cold spells and the risk of hospitalization for asthma: New York, USA 1991–2006 Lung, October 15, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore